Updated hourlyHourly refreshMon, Sep 14, 2026
Press Release Database
Recent press releases, indexed by topic.
Finance · Real Estate
OLDWICK, N.J., September 11, 2026--AM Best has revised the outlooks to negative from stable and affirmed the Financial Strength Rating (FSR) of A- (Excellent) and the Long-Term Issuer Credit Ratings (Long-Term ICRs) of "a-" (Excellent) of the property/casualty subsidiaries and affiliated insurance companies of Kemper Corporation (Kemper) [NYSE: KMPR], collectively referred to as Kemper Property & Casualty Group (Kemper P&C or the group). AM Best also has revised the outlooks to negative from sta
Sep 11 · 20:37·mlpr-businesswire
Finance
HAVERTOWN, Pa., Sept. 11, 2026 (GLOBE NEWSWIRE) -- AMREP Corporation (NYSE:AXR) today reported net income of $276,000, or $0.05 per diluted share, for its 2027 fiscal first quarter ended July 31, 2026 compared to net income of $4,692,000, or $0.87 per diluted share, for the same period of the prior year. Revenues were $6,051,000 for the first quarter of 2027 and $17,851,000 for the first quarter of 2026.
Sep 11 · 20:30·GlobeNewswire
Finance · AI
CAMPBELL, Calif., Sept. 11, 2026 (GLOBE NEWSWIRE) -- Arteris, Inc. (Nasdaq: AIP), a leading technology provider for accelerating semiconductor creation in the AI era, today announced that the company’s board of directors has granted equity awards to Saurabh Sinha, the company’s Chief Financial Officer, as inducement awards material to Mr. Sinha’s acceptance of employment with the company under the company’s 2022 Employment Inducement Incentive Plan. The grants were made in accordance with Nasdaq Listing Rule 5635(c)(4).
Sep 11 · 20:30·GlobeNewswire
Finance · SaaS
NEW YORK, Sept. 11, 2026 (GLOBE NEWSWIRE) -- Cellectis (the “Company”) (Euronext Growth: ALCLS - NASDAQ: CLLS), a clinical-stage biotechnology company using its pioneering gene editing platform to develop life-saving cell and gene therapies, today announced that it will host a conference call and webcast on Monday, September 14, 2026 to provide a business update.
Sep 11 · 20:30·GlobeNewswire
Finance
NEW YORK, 11 sept. 2026 (GLOBE NEWSWIRE) -- Cellectis (Euronext Growth : ALCLS ; Nasdaq : CLLS), société de biotechnologie de stade clinique, qui utilise sa plateforme pionnière d'édition de génome pour développer des thérapies innovantes pour le traitement de maladies graves, annonce aujourd’hui la tenue d’une conférence téléphonique et un webcast le lundi 14 septembre 2026 pour faire un point sur ses activités.
Sep 11 · 20:30·GlobeNewswire
Finance
September 11, 2026
Sep 11 · 20:30·GlobeNewswire
Finance
Frontline plc (the “Company” or “Frontline”) (NYSE: FRO – OSE: FRO) refers to its announcement on August 4, 2026 regarding the sale of two VLCCs. Following the completion of the sale of the two VLCCs, the Board of Directors has declared a special one-time dividend of $0.80 per share, in line with Frontline’s core strategy of returning cash to our shareholders. The special one-time dividend comes in addition to the previously declared dividend of $2.61 per share for the second quarter of 2026.
Sep 11 · 20:30·GlobeNewswire
Finance
VANCOUVER, British Columbia, Sept. 11, 2026 (GLOBE NEWSWIRE) -- Standard Lithium Ltd. (“Standard Lithium” or the “Company”) (TSXV: SLI) (NYSE.A: SLI), a leading near-commercial lithium company, today announced that Karen Narwold will resign from the Company’s Board of Directors (the “Board”), effective September 15, 2026, following her acceptance of a new executive position and the increased time commitments associated with her new role.
Sep 11 · 20:30·GlobeNewswire
Finance
NEW YORK and LONDON, Sept. 11, 2026 /PRNewswire/ -- The Generation Essentials Group (NYSE: TGE; LSE: TGE) ("TGE" or the "Company"), today announced that it has received a letter from the New York Stock Exchange (the "NYSE"), notifying the Company that it is below compliance standards due...
Sep 11 · 20:30·PR Newswire
Finance
New York, New York--(Newsfile Corp. - September 11, 2026) - Kaplan Fox & Kilsheimer LLP announces that a class action lawsuit has been filed against Hyliion Holdings Corp. ("Hyliion" or the "Company") (NYSE American: HYLN) on behalf of investors that purchased or otherwise acquired Hyliion securities between May 12, 2026 and June 23, 2026 (the "Class Period").CLICK HERE TO JOIN THE CASEIf you are an investor in Hyliion and have suffered losses, you may CLICK HERE to contact us. You may also...
Sep 11 · 20:30·mlpr-newsfile
Finance · SaaS
ROCKVILLE, Md., Sept. 11, 2026 (GLOBE NEWSWIRE) -- MaxCyte, Inc. (Nasdaq: MXCT), a leading cell-engineering focused company providing enabling platform technologies to advance the discovery, development and commercialization of next-generation cell therapeutics, reported today that the Compensation Committee of the Board of Directors of MaxCyte granted inducement awards in the form of stock options to purchase an aggregate of 220,000 shares of MaxCyte’s common stock and a service-based restricted stock unit (“RSU”) award with respect to 110,000 shares of MaxCyte’s common stock to Sidharth Kapileshwar, in connection with his commencement of employment as Senior Vice-President, Chief Corporate Development Officer at MaxCyte. The awards were granted under the MaxCyte, Inc. 2026 Inducement Pla
Sep 11 · 20:30·GlobeNewswire
Finance
The Class A ordinary shares will trade under the symbol “RNAQ” and the warrants under the symbol “RNAQW” on The Nasdaq Capital Market, while units that are not separated will continue to trade under the symbol “RNAQU.” The Class A ordinary shares will trade under the symbol “RNAQ” and the warrants under the symbol “RNAQW” on The Nasdaq Capital Market, while units that are not separated will continue to trade under the symbol “RNAQU.”
Sep 11 · 20:30·GlobeNewswire